OSTX - Latest News

OS Therapies Incorporated (OSTX), operates in Healthcare / Biotechnology, trades on AMEX.

Market capitalization stands near $69.0M. Beta to the broader market is -0.83.

The article list below shows the most recent OSTX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent OSTX Headlines

OS Therapies Accepts New FDA Meeting Request to Review Biomarker Data as Part of BEST Program

newsfilecorp.com - Jul 8, 2026

CDER meeting expected to take place in the summer of 2026 in parallel with CBER's Type B Statistical Methods Meeting New York, New York and Rockville,

OS Therapies Third Quarter 2026 Corporate Outlook

newsfilecorp.com - Jul 6, 2026

Upcoming Type B Statistical Methods Meeting expected to set stage for FDA to align with EMA and MHRA on use of Fall 2026 3-year overall survival data

OS Therapies Appoints Dr. Craig Eagle to Board of Directors

newsfilecorp.com - Jul 2, 2026

Company secures $10 million line of credit supported by OS Therapies UK tax credits New York, New York and Rockville, Maryland--(Newsfile Corp. - Jul

OS Therapies Provides U.S. Regulatory Update

newsfilecorp.com - Jun 30, 2026

Type B Meeting requested to follow up on September 2025 End of Phase 2 FDA Meeting guidance on statistical methods to be used for BLA Submission Seeki

OS Animal Health Announces Peer-Reviewed Publication of Clinical Trial Data for OST-HER2 Plus Palliative Radiation as Frontline Treatment in Canine Osteosarcoma

newsfilecorp.com - Jun 26, 2026

20% of OST-HER2 treated dogs survived 2-year vs. 1% in control group (p = 0.

How News Affects OSTX Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track OSTX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked OSTX news questions

What is the latest OSTX news headline?

The most recent OSTX headline (Jul 8, 2026) is "OS Therapies Accepts New FDA Meeting Request to Review Biomarker Data as Part of BEST Program". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the OSTX news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What OSTX news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual OSTX options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.